The end of Alzheimer’s?
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
8 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 8 separate news trends connected to Drug Trials, spanning June 30, 2026 through September 30, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 55 article observations and 49 source signals, led by Business, Health coverage. Use it to compare how individual events emerged, spread and changed over time.
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Two positive Phase III results for an oral multiple sclerosis drug have pushed Novartis forward in a competitive pharmaceutical market.
AstraZeneca's failed heart disease drug trial casts doubt on a promising class of treatments
New cardiovascular treatments are poised to enter the market, with billions of dollars at stake.
A drug used to treat arthritis is showing promise in treating alopecia areata, a condition that causes hair loss.
Amylyx stock surged 55% after its GLP-1 blocker drug met all trial goals
Vertex Pharmaceuticals' stock surges as a rival's cystic fibrosis drug trial fails
A US House committee has launched an investigation into Merck and AbbVie regarding drug trials conducted in China.